HIV

Journal of Antivirals & Antiretroviral is one of the best journals in virology field. All the contents published in this journal are innovative and updated as per the current trend modifications with the development in the technologies and feels new. The main aim of the journal is to provide all the latest information of the latest fields The human immunodeficiency virus (HIV) is a lentivirus that causes the acquired immunodeficiency syndrome. A condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. HIV Therapeutics is mainly focused on finding new and effective therapies that include drug class, and antiretroviral drug combinations that can extend and improve the quality of life for people infected with HIV/AIDS and associated co-infections and complications. It mainly supports research that advances our understanding of HIV and how it causes disease, thereby unlocking new targets for drug development. The goal is to identify new drugs that are less toxic with fewer side effects, promote better adherence, and are readily accessible, particularly in resource-limited settings. Promising medicines are tested in human clinical trials to determine whether they are safe and effective. OMICS Group is among the leading open access publishers with around 700+ peer-reviewed journals with several best quality peer-reviewed articles. It has more than 50,000+ editorial board members in its Editorial Board and many expert reviewers to carry rigorous peer-review process. Apart from this OMICS Group organizes more than 3000+ International Scientific Conferences across the globe. OMICS Group is having support of more than 1000+ Scientific associations, 50,000+ editorial board members and 15 million readers. By submitting research on Antivirals & Antiretrovirals for translation into French, German, Spanish, Chinese, Japanese or English authors and researchers can now reach a truly global audience. With the newly launched OMICS Translation Services we assure highest precision while maintaining the exact purpose and aim of your research paper. The translation process is followed by strict review procedures in order to ensure absolute accuracy. We believe that translation services perform a key role in the emergence of a connected scholarly community.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on September, 2024